Re: Arguedas et al.--Hepatitis A prevention analysis.
Jacobs
R Jake
RJ
Meyerhoff
Allen S
AS
Koff
Raymond S
RS
D003362:Cost-Benefit Analysis; D006506:Hepatitis A / Q000150:complications / Q000191:economics* / Q000453:epidemiology / Q000517:prevention & control*; D022362:Hepatitis A Vaccines / Q000008:administration & dosage / Q000191:economics*; D019698:Hepatitis C, Chronic / Q000150:complications*; D006801:Humans; D019057:Quality-Adjusted Life Years; D014481:United States / Q000453:epidemiology
D022362:Hepatitis A Vaccines